How do I: Evaluate the safety and legitimacy of unproven cellular therapies?

Indira GuleriaMaria de Los Angeles MuñizMatthew WilgoAsawari BapatWanxing CuiYen-Michael Sheng Hsu Naveen Jeyaraman Sathish MuthuFederico RodriguezAndrew D FesnakChristina CelluzziDeborah Sesok-PizziniRonit Reich-SlotkyThomas Spitzer

Published in: Transfusion (2022)

Increasing awareness of the issues associated with unproven therapies through education is important to help in reducing misinformation and risks to patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
social media
prognostic factors
peritoneal dialysis
risk assessment
patient reported outcomes
human health